首页> 外国专利> Bilirubin Derivatives Based Ultrasound Contrast Agent For Theranostics

Bilirubin Derivatives Based Ultrasound Contrast Agent For Theranostics

机译:基于胆红素衍生物的超声造影剂

摘要

The present invention relates to ultrasound contrast agents for diagnosis and treatment based on bilirubin derivatives. The microparticles comprising the bilirubin derivative of the present invention can react sensitively to reactive oxygen species (ROS), bind with hydrophobic drugs, and effectively chelate metals, including iron oxide nanoparticles. Therefore, the microparticles of the present invention can be used not only as a contrast agent for ultrasound diagnosis, but also as a carrier for magnetic resonance imaging contrast agents and hydrophobic and platinum based drugs.
机译:本发明涉及基于胆红素衍生物的诊断和治疗的超声造影剂。包含本发明的胆红素衍生物的微粒可以对活性氧(ROS)敏感地反应,与疏水性药物结合,并有效地螯合金属,包括氧化铁纳米颗粒。因此,本发明的微粒不仅可以用作用于超声诊断的造影剂,而且可以用作磁共振成像造影剂以及基于疏水和铂的药物的载体。

著录项

  • 公开/公告号KR102056948B1

    专利类型

  • 公开/公告日2019-12-17

    原文格式PDF

  • 申请/专利权人 주식회사 빌릭스;

    申请/专利号KR20180014160

  • 发明设计人 전상용;이동윤;이용현;김진용;

    申请日2018-02-05

  • 分类号A61K49/22;A61K31/409;A61K47/69;A61K51/04;A61K9/16;

  • 国家 KR

  • 入库时间 2022-08-21 11:08:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号